Antibiotics and Clostridium difficile: Cause and cure

Journal of Clinical Gastroenterology

Volumn 41, Issue 1, 2007, Pages 1-2

  Surawicz, Christina M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; METRONIDAZOLE; QUINOLONE DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ANTIMICROBIAL THERAPY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA; COLON MUCOSA; COLONOSCOPY; DIAGNOSTIC TEST; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; FECES ANALYSIS; HOSPITAL INFECTION; HUMAN; HYPOALBUMINEMIA; INFECTIOUS DIARRHEA; LUNG TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RECURRENT DISEASE; SIGMOIDOSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CRICETINAE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 33845971567     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225619.24965.aa     Document Type: Editorial

References (12)

1. Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis: a prospective study. Ann Intern Med. 1974;81:429-433.
2. Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978;298:531-534.
3. Chang TW, Laurermann M, Bartlett JG. Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis. 1979;140:765-770.
4. Hecht JR, Olinger EJ. Clostridium difficile colitis secondary to intravenous vancomycin. Dig Dis Sci. 1989;34:148-149.
5. Jung S-W, Jeon S-W, Do B-H, et al. Clinical Aspects of Rifampicin-associated Psuedomembranous Colitis. J Clin Gastroenterol. 2007;41:38-40.
6. Dansinger ML, Johnson S, Jansen PC, et al. Protein-losing enteropathy is associated with Clostridium difficile diarrhea but not with asymptomatic colonization: a prospective, case-control study. Clin Infect Dis. 1996;22:932-937.
7. Bergstein JM, Kramer A, Wittman DH, et al. Pseudomembranous colitis: how useful is endoscopy? Surg Endosc. 1990;4:217-219.
8. Fernandez A, Anand G, Friedenberg F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. Clin Gastronenterol. 2004;38:414-418.
9. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005;40:1586-1590.
10. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-2441.
11. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442-2449.
12. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079-1084.